Acorda Therapeutics Inc - Company Profile

Powered by

All the sales intelligence you need on Acorda Therapeutics Inc in one solution.

$195 $295
Register your interest Learn more
  • Save hours of research time with a comprehensive
    Sales Intelligence Solution.

  • Understand how Acorda Therapeutics Inc fits into your total
    addressable market and Ideal Customer Profile.

  • Gain competitive edge with triggers that tell you
    when and how to engage with Acorda Therapeutics Inc.

Back to companies

Acorda Therapeutics Inc: Overview

Get in touch about GlobalData Company reports

Contact the team or request a demo to find out how our data can drive your business forward

Select Item

Acorda Therapeutics Inc (Acorda), is a biopharmaceutical company that discovers, develops, and markets therapies for treating patients with neurological disorders. The company's portfolio encompasses marketed products for the treatment of multiple sclerosis (MS) and for the intermittent treatment of people with Parkinson’s taking levodopa or carbidopa who experience off episodes. The company sells its products through wholesale pharmaceutical distributors to retail pharmacies and specialty pharmacy providers. It has subsidiaries in the US and Europe. Acorda is headquartered in Ardsley, New York, the US.

 Gain a 360-degree view of Acorda Therapeutics Inc and make more informed decisions for your business Gain a 360-degree view of Acorda Therapeutics Inc and make more informed decisions for your business Learn more
Headquarters United States of America
Address Two Blue Hill Plaza, Pearl River, New York, 10965
Website www.acorda.com
Telephone 1 914 3474300
No of Employees 102
Industry Pharmaceuticals and Healthcare
Revenue (2023) $117.6M
   
   
Gain access to our premium signals and make informed decisions for your business Gain access to our premium signals and make informed decisions for your business Learn more

Acorda Therapeutics Inc premium industry data and analytics

110+

Clinical Trials

Determine Acorda Therapeutics Inc go-to-market proposition and gain insight into the company’s clinical operations, recruitment, and trial strategy.

30+

Pipeline Drugs

Identify which of Acorda Therapeutics Inc’s products will be commercialized, helping you to better contend with shifting product portfolios, and allowing you to stay one step ahead of the market.

30+

Insights

Remove risk and uncertainty, gain a competitive edge and secure actionable leads with access to company-related investigative journalist content.

9

Catalyst Calendar

Proactively evaluate Acorda Therapeutics Inc’s catalyst impacts to stay ahead of the competition & improve corporate planning. Bolster business development with timely opportunities.

4

Sales & Consensus Forecasts

Understand the current and future drug revenue for Acorda Therapeutics Inc and assess market opportunity for new entrants with patient population 8-year forecasts.

4

Regulatory Milestones

Track drug and patent expiries along with geographies impacted.

2

Marketed Drugs

Understand Acorda Therapeutics Inc’s commercialized product portfolio to stay one step ahead of the market.

1

IT Services Contracts

Improve competitive bidding with insights into all publicly disclosed IT services contracts for Acorda Therapeutics Inc (including IT outsourcing, business process outsourcing, systems integration & consulting and more).

Image for loader
Executives
Name Position Board Since Age
Non Dignissim Eros Proin vel Convallis 2026 XY
Non Dignissim Eros Proin vel Convallis 2026 XY
Non Dignissim Eros Proin vel Convallis 2026 XY
Gain insight into Acorda Therapeutics Inc key executives to enhance your sales strategy Gain insight into Acorda Therapeutics Inc key executives to enhance your sales strategy Learn more
Still looking?

Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.

Explorer

Access more premium companies when you subscribe to Explorer

Why are you leaving?